Compare
Agilent Technologies, Inc. vs Bruker Corp vs Revvity, Inc.
| Latest fiscal year | Agilent Technologies, Inc. A | Bruker Corp BRKR | Revvity, Inc. RVTY |
|---|---|---|---|
| Year ended | 2025-10-31 | 2025-12-31 | 2025-12-28 |
| Revenue | $6.95B | $3.44B | $2.86B |
| Revenue growth (YoY) | +6.7% | +2.1% | +3.7% |
| Gross margin | 52.4% (computed) | 45.9% | n/a |
| Operating margin | 21.3% | 2.0% | 12.5% |
| Net margin | 18.8% | -0.2% | 8.4% |
| Net income | $1.30B | -$8.30M | $241.20M |
| EPS (Diluted) | $4.57 | -$0.15 | $2.07 |
| Operating cash flow | $1.56B | $134.10M | $582.93M |
| Free cash flow | $1.15B | $43.30M | $509.41M |
| Cash & equivalents | $1.79B | $298.80M | $919.86M |
| Total assets | $12.73B | $6.24B | $12.17B |
| Total liabilities | $5.99B | $3.73B | $4.92B |
| Shareholders' equity | $6.74B | $2.47B | $7.25B |
| Return on year-end equity | 19.3% | -0.3% | 3.3% |
| Shares outstanding | 283.05M | 152.14M | 112.28M |
Revenue, most recent five fiscal years
| Fiscal year | Agilent Technologies, Inc. | Bruker Corp | Revvity, Inc. |
|---|---|---|---|
| Latest | $6.95B Ended 2025-10-31 | $3.44B Ended 2025-12-31 | $2.86B Ended 2025-12-28 |
| 1 year earlier | $6.51B Ended 2024-10-31 | $3.37B Ended 2024-12-31 | $2.76B Ended 2024-12-29 |
| 2 years earlier | $6.83B Ended 2023-10-31 | $2.96B Ended 2023-12-31 | $2.75B Ended 2023-12-31 |
| 3 years earlier | $6.85B Ended 2022-10-31 | $2.53B Ended 2022-12-31 | $3.31B Ended 2023-01-01 |
| 4 years earlier | $6.32B Ended 2021-10-31 | $2.42B Ended 2021-12-31 | $3.83B Ended 2022-01-02 |